These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. In vitro efficacy of glutaraldehyde-crosslinked chitosan microspheres against the fish-pathogenic ciliate Philasterides dicentrarchi. Paramá A; Luzardo A; Blanco-Méndez J; Sanmartín ML; Leiro J Dis Aquat Organ; 2005 Apr; 64(2):151-8. PubMed ID: 15918478 [TBL] [Abstract][Full Text] [Related]
83. Study on glycolic acid delivery by liposomes and microspheres. Perugini P; Genta I; Pavanetto F; Conti B; Scalia S; Baruffini A Int J Pharm; 2000 Feb; 196(1):51-61. PubMed ID: 10675707 [TBL] [Abstract][Full Text] [Related]
84. Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres. Zhao XL; Li KX; Zhao XF; Pang DH; Chen DW Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):963-8. PubMed ID: 18591810 [TBL] [Abstract][Full Text] [Related]
85. Cross-linked chitosan films: effect of cross-linking density on swelling parameters. Tiwary AK; Rana V Pak J Pharm Sci; 2010 Oct; 23(4):443-8. PubMed ID: 20884460 [TBL] [Abstract][Full Text] [Related]
86. The influence of magnesium stearate on the characteristics of mucoadhesive microspheres. Bogataj M; Mrhar A; Grabnar I; Rajtman Z; Bukovec P; Srcic S; Urleb U J Microencapsul; 2000; 17(4):499-508. PubMed ID: 10898089 [TBL] [Abstract][Full Text] [Related]
87. Chitosan microspheres prepared by an aqueous process: release of indomethacin. Aggarwal A; Kaur S; Tiwary AK; Gupta S J Microencapsul; 2001; 18(6):819-23. PubMed ID: 11695644 [TBL] [Abstract][Full Text] [Related]
88. New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration. Rassu G; Gavini E; Jonassen H; Zambito Y; Fogli S; Breschi MC; Giunchedi P J Pharm Sci; 2009 Dec; 98(12):4852-65. PubMed ID: 19479981 [TBL] [Abstract][Full Text] [Related]
89. Cytotoxicity of 5-fluorouracil entrapped in gelatin microspheres. Muvaffak A; Gürhan I; Hasirci N J Microencapsul; 2004 May; 21(3):293-306. PubMed ID: 15204596 [TBL] [Abstract][Full Text] [Related]
90. Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells. Li PW; Wang G; Yang ZM; Duan W; Peng Z; Kong LX; Wang QH Drug Deliv; 2016; 23(1):30-5. PubMed ID: 24712731 [TBL] [Abstract][Full Text] [Related]
91. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. Shu XZ; Zhu KJ J Microencapsul; 2001; 18(2):237-45. PubMed ID: 11253940 [TBL] [Abstract][Full Text] [Related]
92. Effect of process variables on particle size of gelatin microspheres containing lactic acid. Dinarvand R; Mahmoodi S; Farboud E Pharm Dev Technol; 2004 Aug; 9(3):291-9. PubMed ID: 15458234 [TBL] [Abstract][Full Text] [Related]
93. Cross-linked starch microspheres: effect of cross-linking condition on the microsphere characteristics. Atyabi F; Manoochehri S; Moghadam SH; Dinarvand R Arch Pharm Res; 2006 Dec; 29(12):1179-86. PubMed ID: 17225470 [TBL] [Abstract][Full Text] [Related]
94. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. Elçin YM; Dixit V; Gitnick G Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):257-71. PubMed ID: 8773742 [TBL] [Abstract][Full Text] [Related]
95. Impregnation and release of aspirin from chitosan/poly(acrylic acid) graft copolymer microspheres. Nascimento A; Laranjeira MC; Fávere VT; Josué A J Microencapsul; 2001; 18(5):679-84. PubMed ID: 11508772 [TBL] [Abstract][Full Text] [Related]
96. Hyaluronidase-injectable microparticles intended for the treatment of extravasation. Modena T; Conti B; Genta I; Pauanetto F; Tira ME; Sini P; Gazzaniga A J Microencapsul; 1998; 15(1):85-92. PubMed ID: 9463810 [TBL] [Abstract][Full Text] [Related]
97. Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. Jameela SR; Kumary TV; Lal AV; Jayakrishnan A J Control Release; 1998 Mar; 52(1-2):17-24. PubMed ID: 9685932 [TBL] [Abstract][Full Text] [Related]
98. Formulation and Characterization of Losartan Loaded Chitosan Microspheres: Effect of Crosslinking Agents. Pahuja S; Aggarwal S; Sarup P Drug Res (Stuttg); 2021 Apr; 71(4):204-212. PubMed ID: 33348390 [TBL] [Abstract][Full Text] [Related]
99. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils. Hejazi R; Amiji M Pharm Dev Technol; 2003 Aug; 8(3):253-62. PubMed ID: 12901691 [TBL] [Abstract][Full Text] [Related]
100. Enhancing drug incorporation into tetracycline-loaded chitosan microspheres for periodontal therapy. Govender S; Lutchman D; Pillay V; Chetty DJ; Govender T J Microencapsul; 2006 Nov; 23(7):750-61. PubMed ID: 17123919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]